Trials / Completed
CompletedNCT05515588
A Study in Healthy Men to Test How BI 690517 is Taken up and Handled by the Body
A Phase I, Open-label Trial to Investigate Metabolism, Pharmacokinetics (Following a Mass Balance Design) and Absolute Bioavailability of BI 690517 (C-14) After Oral and Intravenous Administration in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The trial is intended to investigate the basic pharmacokinetics, excretion pathways and metabolism of BI 690517 and its metabolites.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BI 690517 (C-14) | BI 690517 (C-14) |
| DRUG | BI 690517 | BI 690517 |
Timeline
- Start date
- 2022-09-19
- Primary completion
- 2022-11-17
- Completion
- 2022-11-17
- First posted
- 2022-08-25
- Last updated
- 2024-09-20
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT05515588. Inclusion in this directory is not an endorsement.